Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

273.29 +1.58 (+0.58%)
Official Closing Price Updated: 7:00 PM EDT, Sep 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
What's going on in today's session: S&P500 movers
Get insights into the S&P500 index performance on Thursday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Tesla To $450? Here Are 10 Top Analyst Forecasts For Thursday
 
Via Benzinga
These S&P500 stocks are gapping in today's session
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session. 
Via Chartmill
Texas Instruments Posts Better-Than-Expected Results, Joins Community Health Systems, Hasbro, ServiceNow, ResMed And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Earnings Scheduled For April 23, 2025
 
Via Benzinga
Wall Street Rally Extends Into Third Day: What's Driving Markets Thursday?
U.S. equities are pushing higher for a third straight session, eyeing the longest winning streak since the Trump tariff announcement on April 2, as optimism over corporate earnings and easing trade... 
Via Benzinga
Topics Government World Trade
Resmed Stock Rises Pre-Market On Upbeat Earnings, CEO Dismisses Tariff Impact: Retail Is Bullish
Revenue for the three months through the end of March rose 8% to $1.29 billion, in line with analyst estimates. 
Via Stocktwits
Topics Earnings Economy Government
Which S&P500 stocks are moving after the closing bell on Wednesday?
After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top S&P500 gainers and losers in today's after-hours session. 
Via Chartmill
ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations
Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year to $1.29 billion. Its non-GAAP profit of $2.37 per share was in line with... 
Via StockStory
Topics Artificial Intelligence
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025
From Resmed, Inc.
Via GlobeNewswire
Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What's Driving Markets Wednesday?
Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration helped lift investor confidence. 
Via Benzinga
Topics Government
A Look Ahead: ResMed's Earnings Forecast
 
Via Benzinga
Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow
Medical device company ResMed (NYSE:RMD) will be announcing earnings results tomorrow after market close. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
Resmed Names Salli Schwartz as Chief Investor Relations Officer
Former Illumina, MSCI, and Moody’s executive brings extensive experience leading engagement with the global investment community 
From Resmed, Inc.
Via GlobeNewswire
Assessing ResMed: Insights From 5 Financial Analysts
 
Via Benzinga
Why RESMED INC (NYSE:RMD) is a Top Pick for Dividend Investors.
Uncovering Dividend Opportunities with RESMED INC (NYSE:RMD). 
Via Chartmill
Which S&P500 stocks are gapping on Tuesday?
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index. 
Via Chartmill
Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)
Let’s dig into the relative performance of Masimo (NASDAQ:MASI) and its peers as we unravel the now-completed Q4 patient monitoring earnings season. 
Via StockStory
Topics Artificial Intelligence
Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US
FDA-cleared home sleep test provides an effective and simplified solution to obstructive sleep apnea testing and diagnosis 
From Resmed, Inc.
Via GlobeNewswire
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks
Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers. 
Via StockStory
Topics Artificial Intelligence
Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025
From Resmed, Inc.
Via GlobeNewswire
Why RESMED INC (NYSE:RMD) Deserves Consideration as a Quality Investment.
A fundamental analysis of (NYSE:RMD): Is RESMED INC (NYSE:RMD) suited for quality investing? 
Via Chartmill
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers
Let’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient monitoring earnings season. 
Via StockStory
Topics Artificial Intelligence
New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer
Largest ever meta-analysis on the long-term benefits of CPAP therapy, published in The Lancet Respiratory Medicine, found that in people with sleep apnea, CPAP therapy lowered the overall chance of... 
From Resmed, Inc.
Via GlobeNewswire
Tempted To Dump Stock? Consider Shifting To Low Vol Stocks / ETFs Instead
While plummeting stock indexes sent some investors screaming for the exits, others look to shift assets from large-cap tech stocks and cap-weighted ETFs into less volatile investments.. 
Via Talk Markets
Topics ETFs Stocks / Equities
Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
Brand Evolution Unites Brands Under One Resmed Identity to Make Better Sleep and Breathing Health More Accessible to Everyone 
From Resmed, Inc.
Via GlobeNewswire
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ResMed (NYSE:RMD) and the rest... 
Via StockStory
Topics Artificial Intelligence
Top S&P500 movers in Monday's session
Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
ResMed Among Top Stocks For Recent And Long-Term Profit Growth
A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue? 
Via Investor's Business Daily
Exploring the top movers within the S&P500 index during today's session.
Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.